HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J-L Achard Selected Research

Antineoplastic Agents (Antineoplastics)

5/2003Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J-L Achard Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
05/2003 - 04/2002
1Inflammatory Breast Neoplasms
12/2015
1Sialorrhea
06/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2013
1Erectile Dysfunction
12/2009
1Prostatic Neoplasms (Prostate Cancer)
12/2009
1Macular Degeneration (Age-Related Maculopathy)
12/2003
1Neutropenia
05/2003
1Sepsis (Septicemia)
05/2003

Drug/Important Bio-Agent (IBA)

1Docetaxel (Taxotere)FDA Link
05/2003
1Antineoplastic Agents (Antineoplastics)IBA
05/2003

Therapy/Procedure

3Neoadjuvant Therapy
12/2015 - 04/2002
3Radiotherapy
06/2013 - 12/2003
1Chemoradiotherapy
12/2015
1Drug Therapy (Chemotherapy)
12/2015
1Therapeutics
12/2015
1Mastectomy (Mammectomy)
12/2015
1Brachytherapy
12/2009
1Induction Chemotherapy
04/2002